AstraZeneca ups stake in Cellectis in latest cell therapy bet May 6, 2024 BioPharma United Kingdom Mark Dunoyer Jack Allen Tyrell Rivers Neogene Therapeutics Gracell Biotechnologies Source: biopharmadive.com Share this article:
AstraZeneca celebrates latest successful trial of acoramidis in Japan February 2, 2024 AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan. The Cambridge,... City Of United Kingdom Astrazeneca Alexion Emma Curzon Mark Dunoyer Bio Pharma Inc Source: marketscreener.com Share this article: